Retinitis Pigmentosa Epidemiology
Retinitis Pigmentosa Epidemiology Insights and Trends
- The total Retinitis Pigmentosa Diagnosed Prevalent Cases were ~274,000 in the 7MM in 2025.
- Retinitis Pigmentosa is a rare inherited retinal condition with a global Retinitis Pigmentosa Prevalence of approximately 1 in 3,000–4,000 individuals. It is a major contributor to genetic visual impairment and progressive blindness worldwide. Typically, Retinitis Pigmentosa Patients begin experiencing vision loss as young adults, with a progression to blindness by age 40.
- More than 80 genes have been linked to retinitis pigmentosa, underscoring its marked genetic heterogeneity. The disease also shows considerable intra- and interfamilial variability in age of onset, disease severity, progression, and clinical features. X-linked retinitis pigmentosa typically presents in childhood and is characterized by a rapid decline in vision.
- Although retinitis pigmentosa mainly affects the eyes, about 20–30% of cases are associated with syndromic or systemic conditions, most commonly Usher syndrome (hearing loss and balance issues) and Bardet-Biedl syndrome (intellectual disability, Obesity, polydactyly, Hypogonadism, and kidney abnormalities).
- Approximately 50–60% of retinitis pigmentosa cases follow an autosomal recessive inheritance pattern, 30–40% are autosomal dominant, and 5–15% are X-linked. The remaining cases are attributed to digenic, maternal mitochondrial, or other non-mendelian inheritance patterns.
- Retinitis Pigmentosa shows a largely gender-neutral distribution (with more severe expression in males in X-linked forms), variable onset from childhood to early adulthood due to genetic heterogeneity, and an age-related increase in prevalence driven by its slow progression and normal life expectancy.
- In Retinitis Pigmentosa, the increasing use of genetic testing is improving diagnosis rates, although the true epidemiological burden is likely underestimated due to misdiagnosis, lack of registries, and variable clinical presentation.
Retinitis Pigmentosa Epidemiology Forecast in the 7MM
- 2025 Retinitis Pigmentosa Diagnosed Prevalent Cases: ~274,000
- Retinitis Pigmentosa Growth Rate (2026–2036): 0.3% CAGR
DelveInsight's ‘Retinitis Pigmentosa Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the retinitis pigmentosa, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Scope of the Retinitis Pigmentosa Epidemiology Report | |
|
Study Period |
2022–2036 |
|
Historical Year |
2022–2025 |
|
Forecast Period |
2026–2036 |
|
Base Year |
2026 |
|
Geographies Covered |
|
|
Retinitis Pigmentosa Epidemiology CAGR | |
|
Retinitis Pigmentosa Epidemiology Segmentation Analysis |
Patient Burden Assessment
|
Retinitis Pigmentosa Understanding and Diagnosis Algorithm
Retinitis Pigmentosa Overview and Diagnosis
Retinitis pigmentosa is a group of inherited retinal disorders that cause progressive degeneration of rod and cone photoreceptors, leading to gradual vision loss. It typically begins with night blindness, followed by loss of peripheral vision (tunnel vision), and may eventually affect central vision. The condition is caused by genetic mutations (autosomal dominant, recessive, or X-linked), and currently, there is no universal cure, with treatment mainly focused on supportive care and slowing progression.
Retinitis Pigmentosa Diagnosis
Diagnosis of retinitis pigmentosa involves a combination of clinical assessment and advanced diagnostic tests. A detailed ophthalmic examination (including fundus evaluation) reveals characteristic changes such as bone-spicule pigmentation, attenuated vessels, and optic disc pallor. Visual field testing helps detect progressive peripheral vision loss, while electroretinography (ERG) confirms reduced rod and cone activity. Additional tests such as optical coherence tomography (OCT) and fundus autofluorescence imaging assess retinal structure and disease progression, and genetic testing is used to identify causative mutations and support definitive diagnosis.
Retinitis Pigmentosa Epidemiology
Key Findings from Retinitis Pigmentosa Epidemiological Analysis and Forecast
- According to DelveInsight’s analysis, autosomal dominant retinitis pigmentosa had the highest number of cases (about 22,000) among the common forms of non-syndromic retinitis pigmentosa, including autosomal recessive, X-linked, sporadic/simplex, and LCA in the US in 2025.
- As per DelveInsight’s estimates, the US accounted for around 113,000 diagnosed prevalent cases of retinitis pigmentosa in 2025. These cases are expected to increase during the forecast period.
- Non-syndromic retinitis pigmentosa was more prevalent than syndromic retinitis pigmentosa with ~73,000 cases in 2025 in the US.
- RPE65-linked inherited retinal diseases account for about 3–16% of Leber Congenital Amaurosis (LCA2) and approximately 0.6–6% of retinitis pigmentosa.
Retinitis Pigmentosa Epidemiology Segmentation in the 7MM
- Total Retinitis Pigmentosa Diagnosed Prevalent Cases
- Retinitis Pigmentosa Gender-specific Diagnosed Prevalent Cases
- Retinitis Pigmentosa Type-specific Diagnosed Prevalent Cases
- Retinitis Pigmentosa Sub-type Specific Diagnosed Prevalent Cases of Syndromic and Systemic
- Retinitis Pigmentosa Sub-type Specific Diagnosed Prevalent Cases of Non-syndromic
- Total Retinitis Pigmentosa Treated Cases
Scope of the Retinitis Pigmentosa Epidemiology Report
- The Retinitis Pigmentosa Epidemiology Report covers a segment of an executive summary, a descriptive overview, explaining its causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Retinitis Pigmentosa Epidemiology Report Insights
- Retinitis Pigmentosa Patient Population Forecast
Retinitis Pigmentosa Epidemiology Report Key Strengths
- Epidemiology-based (Epi-based) Bottom-up Forecasting
- 11-year Retinitis Pigmentosa Forecast
- Patient Burden Trends (by geography)
Key Questions Answered in the Retinitis Pigmentosa Epidemiology Forecast
- What are the disease risks, burdens, and unmet needs of retinitis pigmentosa? What will be the growth opportunities across the 7MM concerning the patient population with retinitis pigmentosa?
- What is the historical and forecasted retinitis pigmentosa patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy the Retinitis Pigmentosa Epidemiology Report
- Insights on patient burden/disease Retinitis Pigmentosa Prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
Stay updated with us for Recent Articles @ New DelveInsight Blogs
